Healthcare Providers

Advanced AI Breast Screening
for Hospitals & Clinics

Thermalytix® is an AI-powered breast screening tool designed to assist Healthcare Providers in the early detection of breast abnormalities. It complements existing methods and serves as a valuable adjunct tool for dense breast evaluation.

Thermalytix is validated through published studies and certified globally, building trust and credibility. It is portable, radiation-free, and contact-free. For patients, Thermalytix® makes screening painless, private, and accessible.

What sets it apart is the unique combination of clinical credibility, operational ease, and patient comfort. A rare balance that strengthens breast health programmes end to end.

300,000+
Women Screened

22+
Countries Reached

39
Patents Granted

Why It Matters for Your Practice

Adjunct Tool

Complements Mammography and Ultrasound to broaden screening programmes.

Seamless Integration

Portable, quick setup in OPDs, outreach camps and mobile units.

Operational Value

Affordable compared to traditional imaging costs.

Dense Breast Support

Provides valuable breast health support for dense tissue cases, suitable for women 18 to 80 years.

Preventive Care Integration

Seamlessly included in master health checks, insurance and wellness packages.

Regulatory Clearance

Employer Logos

Clinical Evidence & Publications

BMJ Open
Multi-centric study validating Thermalytix as compared to standard screening.
Read More
ASCO JCO
Observational study on the clinical efficacy in symptomatic and asymptomatic women.
Read More
Frontiers in AI Journal
Prospective evaluation of breast thermography with a novel ML technique.
Read More
Int. J Community Medicine
Feasibility and outcomes of Thermalytix at primary health centres.
Read More
Lancet Oncology
Real-world evaluation of AI-based screening.
Read More
SABCS 2022
Automated Risk Stratification using Thermalytix.
Read More

Trusted by Leading Medical Institutions

Employer Logos

Frequently Asked Questions

Is it suitable for women under 40?
Yes. Validated for women aged 18–80, including dense tissue cases.
What infrastructure is required?
The screening room should be a closed space with a minimum size of 6 ft. x 8 ft., equipped with an adequate cooling facility – either a wall-mounted air conditioner or a tower air-cooler.
How quickly are reports generated?
Typically within 1-2 working days.
Is Thermalytix regulatory approved?
Thermalytix® is clincally validated and approved by CDSCO (Central Drugs Standard Control Organisation) India. CE approved in Europe, Africa and Asia. It is successfully being used in hospitals and screening programmes across India and abroad.

Join leading Hospitals Worldwide in adopting Thermalytix®

Partner With Us